Talphera, Inc. (TLPH)
NASDAQ: TLPH · Real-Time Price · USD
0.4305
-0.0095 (-2.16%)
At close: Jun 24, 2025, 4:00 PM
0.4304
-0.0001 (-0.02%)
Pre-market: Jun 25, 2025, 8:34 AM EDT
Talphera Employees
Talphera had 13 employees as of December 31, 2024. The number of employees decreased by 2 or -13.33% compared to the previous year.
Employees
13
Change (1Y)
-2
Growth (1Y)
-13.33%
Revenue / Employee
$2,077
Profits / Employee
-$895,615
Market Cap
8.83M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
TLPH News
- 5 weeks ago - Talphera, Inc. (TLPH) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 6 weeks ago - Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 14, 2025 - PRNewsWire
- 3 months ago - Talphera, Inc. (TLPH) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 3 months ago - Talphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to $14.8 Million - PRNewsWire
- 3 months ago - Talphera to Host Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update Call and Webcast on Monday, March 31, 2025 - PRNewsWire
- 5 months ago - Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study - PRNewsWire